Fingerprint
Dive into the research topics of 'Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically